The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Suman P Shah

Ownership Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.0%Reaction day

₹34.23

prior close

₹32.52

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.8%-4.2% vs market

Pharmaceuticals peers, median of 153sector-0.8%-4.2% vs sector

On the reaction day the stock moved 4.2 pts less than Nifty Microcap 250 and 4.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.0-0.8-4.2-0.8-4.2

Next day

-0.8-0.8+0.0-1.0+0.2

+4.1+0.6+3.6-0.1+4.2

+9.3+0.8+8.6-0.2+9.5

+14.8+1.7+13.1+0.7+14.1

+17.6+2.0+15.6+0.3+17.3

+24.1+1.3+22.8+1.6+22.5

15d

+27.1-7.1+34.2-5.9+33.0

+18.3-6.8+25.1-7.8+26.0

+34.4-7.1+41.5-8.6+43.0

+41.2-15.7+57.0-16.7+57.9

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 153Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Suman P Shah, a promoter of Bacil Pharma Limited, sold 500 equity shares through a market sale on 24 December 2025. Before the transaction, she held 500 shares (0.00% of total voting capital), and after the sale her holding is nil. The total equity share capital of the company is 1,43,53,000 shares of Rs. 10 each, and the diluted share capital remains unchanged. The disclosure was filed under Regulation 29(2) of SEBI (SAST) Regulations, 2011. The transaction size is negligible, representing effectively 0% of the company's share capital.

Likely market impact

This is a routine regulatory disclosure of an extremely small share sale by an individual promoter and is unlikely to have any material effect on the stock price or shareholder sentiment.